We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SPRB market cap is 18.07M. The company's latest EPS is USD -1.1602 and P/E is -0.37.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.07M | 2.89M | 2M | 1.61M | 602k |
| Operating Income | -13.66M | -11.16M | -12.63M | -10.04M | -9.41M |
| Net Income | -12.35M | -9.95M | -11.63M | -9.18M | -8.67M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 10.09M |
| Operating Income | -13.11M | -29.42M | -42.07M | -47.28M | -51.99M |
| Net Income | -13.09M | -29.54M | -42.29M | -46.18M | -47.92M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 112.99M | 103.95M | 87.54M | 75.52M | 65.1M |
| Total Liabilities | 27.6M | 27.44M | 20.92M | 16.35M | 13.46M |
| Total Equity | 85.38M | 76.51M | 66.62M | 59.17M | 51.64M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.69M | 162.88M | 126.49M | 85.65M | 103.95M |
| Total Liabilities | 7.52M | 13.46M | 15.12M | 17.16M | 27.44M |
| Total Equity | -30.64M | 149.43M | 111.37M | 68.49M | 76.51M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.07M | -33.28M | -14.96M | -26.06M | -35.29M |
| Investing | 46.48M | 55.78M | N/A | N/A | N/A |
| Financing | 49.69M | 49.14M | -227k | -592k | -997k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.62M | -27.52M | -35.88M | -41.68M | -33.28M |
| Investing | -4k | -74k | -79.17M | 23.69M | 55.78M |
| Financing | 12.43M | 181.04M | 643k | -241k | 49.14M |
| Market Cap | 18.07M |
| Price to Earnings Ratio | -0.37 |
| Price to Sales Ratio | 1.76 |
| Price to Cash Ratio | 0.18 |
| Price to Book Ratio | 0.23 |
| Dividend Yield | - |
| Shares Outstanding | 41.3M |
| Average Volume (1 week) | 546.49k |
| Average Volume (1 Month) | 929.49k |
| 52 Week Change | -83.04% |
| 52 Week High | 5.95 |
| 52 Week Low | 0.365 |
| Spread (Intraday) | 0.02 (4.32%) |
| Company Name | Spruce Biosciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.sprucebiosciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
